Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Porta

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Molecular Vision|January 5, 2017
Somatostatin protects photoreceptor cells against high glucose-induced apoptosisAna I Arroba, Aurora Mazzeo, Daniele Cazzoni, et al.
Acta Diabetologica|August 25, 2016
Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathyElena Beltramo, Tatiana Lopatina, Aurora Mazzeo, et al.
Diabetes Care|February 11, 2012
Infant and toddler type 1 diabetes: complications after 20 years' durationSilvana Salardi, Massimo Porta, Giulio Maltoni, et al.
Lancet (London, England)|October 1, 2008
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsNish Chaturvedi, Massimo Porta, Ronald Klein, et al.
Lancet (London, England)|October 1, 2008
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialAnne Katrin Sjølie, Ronald Klein, Massimo Porta, et al.
Annals of Internal Medicine|May 20, 2009
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trialsRudy Bilous, Nish Chaturvedi, Anne Katrin Sjølie, et al.
Acta Diabetologica|October 29, 2014
Prevalence of retinopathy in patients with type 1 diabetes diagnosed before and after pubertyMassimo Porta, Francesca Schellino, Marcello Montanaro, et al.
Endocrine|September 16, 2016
Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trialMarina Trento, Olga Durando, Sonia Lavecchia, et al.
Southern Medical Journal|May 3, 2022
Multidrug-Resistant Bloodstream Infections in Internal Medicine: Results from a Single-Center StudyEdoardo Pace, Christian Bracco, Corrado Magnino, et al.
Ophthalmic Epidemiology|January 21, 2020
Why Miss the Chance? Incidental Findings while Telescreening for Diabetic RetinopathyLeonardo Mastropasqua, Roberto Perilli, Rossella D'Aloisio, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Molecular Vision|January 5, 2017
Somatostatin protects photoreceptor cells against high glucose-induced apoptosisAna I Arroba, Aurora Mazzeo, Daniele Cazzoni, et al.
Acta Diabetologica|August 25, 2016
Effects of the neuroprotective drugs somatostatin and brimonidine on retinal cell models of diabetic retinopathyElena Beltramo, Tatiana Lopatina, Aurora Mazzeo, et al.
Diabetes Care|February 11, 2012
Infant and toddler type 1 diabetes: complications after 20 years' durationSilvana Salardi, Massimo Porta, Giulio Maltoni, et al.
Lancet (London, England)|October 1, 2008
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsNish Chaturvedi, Massimo Porta, Ronald Klein, et al.
Lancet (London, England)|October 1, 2008
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialAnne Katrin Sjølie, Ronald Klein, Massimo Porta, et al.
Annals of Internal Medicine|May 20, 2009
Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trialsRudy Bilous, Nish Chaturvedi, Anne Katrin Sjølie, et al.
Acta Diabetologica|October 29, 2014
Prevalence of retinopathy in patients with type 1 diabetes diagnosed before and after pubertyMassimo Porta, Francesca Schellino, Marcello Montanaro, et al.
Endocrine|September 16, 2016
Vision related quality of life in patients with type 2 diabetes in the EUROCONDOR trialMarina Trento, Olga Durando, Sonia Lavecchia, et al.
Southern Medical Journal|May 3, 2022
Multidrug-Resistant Bloodstream Infections in Internal Medicine: Results from a Single-Center StudyEdoardo Pace, Christian Bracco, Corrado Magnino, et al.
Ophthalmic Epidemiology|January 21, 2020
Why Miss the Chance? Incidental Findings while Telescreening for Diabetic RetinopathyLeonardo Mastropasqua, Roberto Perilli, Rossella D'Aloisio, et al.
Pageof 10